WallStSmart
GRCE

Grace Therapeutics, Inc.

NASDAQ: GRCE · HEALTHCARE · BIOTECHNOLOGY

$2.10
+0.00% today

Updated 2026-04-29

Market cap
$33.42M
P/E ratio
P/S ratio
197.75x
EPS (TTM)
$-0.31
Dividend yield
52W range
$2 – $5
Volume
0.8M

Grace Therapeutics, Inc. (GRCE) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item2010201120122013201420152016201720182019202020212022202320242025
Total assets$8.90M$11.07M$15.82M$11.89M$41.01M$29.74M$21.04M$17.78M$36.90M$22.85M$62.46M$128.62M$79.12M$73.30M$71.99M
Cash & equivalents$404965.00$329430.00$1.60M$1.17M$607094.00$1.05M$2.23M$6.37M$16.87M$14.24M$50.94M$30.34M$27.88M$23.00M$22.13M
Current assets$866654.00$3.36M$8.91M$5.72M$23.20M$15.70M$8.36M$7.35M$27.97M$15.96M$62.37M$45.53M$29.29M$24.01M$22.71M
Total liabilities$4.88M$5.24M$1.27M$2.39M$11.10M$3.18M$957117.00$11.41M$25.85M$9.86M$6.80M$20.35M$11.17M$11.56M$5.38M
Current liabilities$4.88M$5.24M$1.27M$2.39M$1.05M$1.30M$841998.00$5.19M$13.67M$7.39M$1.58M$3.26M$3.41M$1.68M$1.93M
Long-term debt
Shareholder equity$4.02M$5.83M$14.55M$9.50M$29.91M$26.56M$20.09M$6.37M$11.04M$12.99M$55.66M$108.27M$67.95M$61.74M$66.61M
Retained earnings$-3.57M$-6.80M$-13.23M$-19.58M$-28.45M$-26.62M$-29.24M$-56.05M$-100.83M$-126.34M$-146.02M$-155.84M$-198.27M$-211.12M$-220.69M
Accounts receivable$461689.00$456156.00$1.09M$816602.00$1.03M$682989.00$294441.00$587729.00$1.19M$546000.00$530000.00$548000.00$802000.00$722000.00$126000.00
Inventory$2.00$602934.00$216971.00$234960.00$69830.00$1.00
Goodwill$0.00$12.96M$8.14M$8.14M$8.14M